Developmental Research Program

发展研究方案摘要/摘要 发展研究计划(DRP)的目的是资助研究人员有前途的项目 他们目前的工作可能并不完全集中在卵巢癌上，但他们提出了高度创新的建议 卵巢癌的翻译研究可能成为全孢子项目或竞争成功 在孢子外提供资金。DRP提供了一个独特的机会，使大量的资金 支持，并通过一个迅速响应新的 想法或倡议。此外，这项计划植根于孢子推动的合作精神。 有将其他学科的调查人员带入卵巢的广泛记录的调查人员 癌症研究。民主同盟党的力量在于它有能力提供必要的财政支持，以便 获取整个孢子内的所有关键专业知识和资源。这将使我们能够发展 在创新研究人员的支持下，协作、多研究人员、多机构的研究项目- 启动的项目有可能发展为可靠和富有成效的翻译研究项目 这使得从基础和/或人口研究项目进入专注于人类临床的研究 样本/患者群体。在过去的十年里，MD Anderson OvaranSPORE 支持来自22名调查人员的DRP项目。这些调查人员总共发表了470篇同行-- 审阅了与卵巢癌相关的手稿。其中13名获奖者已经收到了同行评审的资助 在卵巢癌中作为PI、Co-PI或Co-Investigator。调查人员已经收到了三家公司的资助 R01，三个R21，三个CPRIT奖，两个国防部奖和四个OCRA奖。一 最近资助周期的获奖者刚刚得到了卵巢癌研究联盟和 妇女癌症基金会。此外，三位前获奖者参与了全孢子项目。 在完成DRP项目之后。

Developmental Research Program SUMMARY/ABSTRACT The purpose of the Developmental Research Program (DRP) is to fund promising projects by investigators whose current work may not focus exclusively on ovarian cancer, but who propose highly innovative translational studies of ovarian cancer that could become full SPORE projects or compete successfully for funding outside of the SPORE. The DRP provides a unique opportunity for making available significant financial support, and for demonstrating active institutional support, through a program that is rapidly responsiveto new ideas or initiatives. Moreover, this program is rooted in a spirit of collaboration promoted by the SPORE investigators who have an extensive track record of bringing investigators from other disciplines into ovarian cancer research. The strength of the DRP rests in its ability to make available financial support needed to access all the critical expertise and resources within the entire SPORE. This will allow us to develop collaborative, multi-investigator, multi-institutional research projects with the support of innovative, investigator- initiated projects that have the potential to flourish into reliable and productive translational research projects that make a path from basic and/or population research projects into research focused on human clinical specimens/patient populations. Over the course of the past decade, the MD Anderson OvarianSPORE has supported DRP projects from 22 investigators. Collectively, these investigators have published 470 peer- reviewed manuscripts related to ovarian cancer. Thirteen of the recipients have received peer-reviewedfunding in ovarian cancer as either PI, Co-PI or Co-Investigator. The investigators have received funding from three R01s, three R21s, three CPRIT awards, two Department of Defense Awards and four OCRA awards. One awardee in the most recently funded cycle just received support from both the Ovarian Cancer Research Alliance and Foundation for Women’s Cancer. Additionally, three former awardees have participated in full SPORE projects after completing a DRP project.